Comparing the Effect of Vimala Massage Versus Hydrotherapy on the Clinical Outcomes of Neonatal Hyperbilirubinemia
NCT ID: NCT06595368
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2024-07-01
2025-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pacifier Use During Phototherapy in Newborns With Hyperbilirubinemia
NCT06498765
Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia
NCT05077787
Acupressure Therapy Method and Heel Blood Effect of Position on Pain and Physiological Parameters
NCT06214104
Effect of Leg and Heel Massage on Pain During Heel Blood Collection Newborns
NCT06567093
Shotblocker and Breastfeeding on Pain/Comfort During Heel Lance
NCT05246787
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Control Group: Consisted of 30 newborns who will receive conventional hospital care with no additional interventions.
Study Group (I): Consisted of 30 neonates who will receive Vimala massage. The massage will be given three times per day, each lasting 15 minutes and planned one hour after the first feeding of each shift.
Study Group (II): Consisted of 30 neonates who will receive hydrotherapy. It will be applied two times per day before feeding, each lasting 5-10 min.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Consisted of 30 newborns who will receive conventional hospital care with no additional interventions.
No interventions assigned to this group
Study group I (Vimala group)
Consisted of 30 neonates who will receive Vimala massage.
Vimala massage
The massage will be given three times per day, each lasting 15 minutes and planned one hour after the first feeding of each shift.
Study group II (Hydrotherapy)
Consisted of 30 neonates who will receive hydrotherapy.
Hydrotherapy
Hydrotherapy will be applied two times per day before feeding, each lasting 5-10 min.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vimala massage
The massage will be given three times per day, each lasting 15 minutes and planned one hour after the first feeding of each shift.
Hydrotherapy
Hydrotherapy will be applied two times per day before feeding, each lasting 5-10 min.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
37 Weeks
42 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman Wardany Abdelaal Mohamed
assistant professor of pediatric nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafrelsheikh University
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KafrelsheikhU3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.